In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...